Open Innovation Tackles NCDs in Africa
The Devex Impact website reported that to understand more about Africa’s increasing noncommunicable diseases (NCD) threat, we need to bring together the brightest scientific minds to work as a team rather than struggling alone to find answers. No single country in the region has enough researchers with the appropriate mix of skills required to tackle
Comments Off on Open Innovation Tackles NCDs in Africa • Read this story »
More Articles
GlaxoSmithKline: Funding Open Innovation
The 4-Traders website reported that GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world. The funding will move early-stage research
Comments Off on GlaxoSmithKline: Funding Open Innovation • Read this story »
Will Pharma Embrace Open Innovation?
The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of
Comments Off on Will Pharma Embrace Open Innovation? • Read this story »
Big Pharma’s Open Innovation Initiatives Zoom In on Discovery
For biotechnology and pharmaceutical businesses, the open-source model holds potential for advancing drug discovery faster and at lower cost than the model now in place. The current system emphasizes developing and protecting proprietary intellectual property, then spending years and additional dollars